Get the Stockscreener App
0.3701
8.28%
-0.0334
After Hours:
.36
-0.0101
-2.73%
X 4 Pharmaceuticals Inc Stock (XFOR) Forecast
The X 4 Pharmaceuticals Inc (XFOR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.8917, representing a +1,492% increase from the current price of $0.3701. The highest analyst price target is $6.3435, and the lowest is $5.44.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XFOR Price Target
Average 6.8717
(+1,757% Upside)
Is X 4 Pharmaceuticals Inc (XFOR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.96 | Neutral |
| STOCH(9,6) | 40.72 | Neutral |
| STOCHRSI(14) | 26.89 | Neutral |
| MACD(12,26) | -0.0392 | Sell |
| ADX(14) | 33.20 | Sell |
| William %R | -74.00 | Neutral |
| CCI(14) | -122.29 | Sell |
Buy: 0
Sell: 3
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5086
Sell
|
0.4653
Sell
|
| MA20 |
0.5067
Sell
|
0.5004
Sell
|
| MA50 |
0.5745
Sell
|
0.5633
Sell
|
| MA100 |
0.6352
Sell
|
0.6526
Sell
|
| MA200 |
0.8485
Sell
|
0.774
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, XFOR could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 13 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on XFOR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.96 indicates that XFOR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.72 indicates that XFOR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.89 indicates that XFOR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.2 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -122.29 indicates that XFOR is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term XFOR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about X 4 Pharmaceuticals Inc financial reports and earnings history, X 4 Pharmaceuticals Inc (XFOR) stock could reach $24.79 by 2030, $14.99 by 2040 and $46.52 by 2050. See the projected annual prices until 2050 of the X 4 Pharmaceuticals Inc stock below:
- X 4 Pharmaceuticals Inc (XFOR) is expected to reach an average price of $4.9633 in 2035, with a high prediction of $5.423 and a low estimate of $5.008. This indicates an $1,241% rise from the last recorded price of $0.3701.
- X 4 Pharmaceuticals Inc (XFOR) stock is projected to chart a bullish course in 2040, with an average price target of $13.86, representing an $3,644% surge from its current level. The forecast ranges from a conservative $14.14 to a sky-high $14.99.
- Our analysts predict X 4 Pharmaceuticals Inc (XFOR) to jump 7,163% by 2045, soaring from $27.61 to an average price of $26.88, potentially reaching $28.65. While $27.61 is the low estimate, the potential upside is significant.
- X 4 Pharmaceuticals Inc (XFOR) stock is expected to climb by 2050, reaching an average of $45.48, a $12,189% jump from its current level. However, a wide range of estimates exists, with high and low targets of $46.52 and $45.51, respectively, highlighting the market's uncertainty.
X 4 Pharmaceuticals Inc Stock (XFOR) Year by Year Forecast
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2024
Our forecast for XFOR stock price in 2024 now indicates an average price target of $3.9769 with a high forecast of $7.2535 and a low forecast of $0.7004. The average prediction reflects an increase of +974.56% from the last recorded price of $0.3701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $7.3335 | $5.44 | $6.3435 | +1,881% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2025
X 4 Pharmaceuticals Inc Stock (XFOR) is expected to reach an average price of $7.705 in 2025, with a high prediction of $8.3035 and a low estimate of $7.1065. This indicates an +1,982% rise from the last recorded price of $0.3701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.876 | $7.136 | $6.9425 | +1,758% |
| February, 2025 | $9.279 | $7.5005 | $8.054 | +2,407% |
| March, 2025 | $6.742 | $7.472 | $8.3035 | +1,722% |
| April, 2025 | $8.4845 | $7.6665 | $8.0945 | +2,192% |
| May, 2025 | $7.0825 | $7.1725 | $7.289 | +1,814% |
| June, 2025 | $7.5805 | $7.747 | $7.0915 | +1,948% |
| July, 2025 | $6.363 | $7.744 | $7.3095 | +1,619% |
| August, 2025 | $7.731 | $7.1065 | $6.661 | +1,989% |
| September, 2025 | $7.269 | $7.78 | $7.3855 | +1,864% |
| October, 2025 | $7.0015 | $7.178 | $6.7415 | +1,792% |
| November, 2025 | $8.2295 | $7.696 | $7.8605 | +2,124% |
| December, 2025 | $8.932 | $8.2085 | $8.112 | +2,313% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2026
The predicted value for X 4 Pharmaceuticals Inc (XFOR) in 2026 is set at an average of $5.8235. Estimates vary from a peak of $8.0165 to a trough of $3.6305, indicating an +1,473% surge from the present price of $0.3701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.61 | $8.2455 | $8.0165 | +1,956% |
| February, 2026 | $7.698 | $7.809 | $7.4145 | +1,980% |
| March, 2026 | $5.386 | $6.2559 | $7.0025 | +1,355% |
| April, 2026 | $3.9185 | $4.9985 | $5.2195 | +958.77% |
| May, 2026 | $3.3965 | $4.032 | $3.433 | +817.72% |
| June, 2026 | $4.0145 | $4.4045 | $4.0155 | +984.70% |
| July, 2026 | $5.077 | $4.3035 | $4.2075 | +1,272% |
| August, 2026 | $3.705 | $3.6305 | $4.6215 | +901.08% |
| September, 2026 | $5.7875 | $4.9895 | $5.7375 | +1,464% |
| October, 2026 | $5.7455 | $6.2955 | $6.0165 | +1,452% |
| November, 2026 | $6.4635 | $6.18 | $6.479 | +1,646% |
| December, 2026 | $5.93 | $6.186 | $6.268 | +1,502% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for X 4 Pharmaceuticals Inc (XFOR) is $6.9795, with a high forecast of $8.0695 and a low forecast of $5.8895. This indicates an +1,786% increase from the last price of $0.3701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.504 | $5.8895 | $5.8705 | +1,657% |
| February, 2027 | $5.962 | $6.042 | $5.8185 | +1,511% |
| March, 2027 | $7.9445 | $6.361 | $7.1845 | +2,047% |
| April, 2027 | $8.0625 | $8.068 | $7.8325 | +2,078% |
| May, 2027 | $8.0405 | $8.036 | $8.0615 | +2,073% |
| June, 2027 | $7.563 | $8.063 | $8.0695 | +1,943% |
| July, 2027 | $7.551 | $7.5475 | $7.302 | +1,940% |
| August, 2027 | $7.739 | $7.4455 | $7.509 | +1,991% |
| September, 2027 | $7.4615 | $7.6415 | $7.6325 | +1,916% |
| October, 2027 | $7.3695 | $7.425 | $7.396 | +1,891% |
| November, 2027 | $7.0675 | $7.2175 | $7.207 | +1,810% |
| December, 2027 | $6.44 | $6.75 | $6.942 | +1,640% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2028
In 2028, X 4 Pharmaceuticals Inc (XFOR) is projected to reach an average price of $4.6092, with a high projection of $6.5935 and a low estimate of $2.625. This indicates an +1,145% rise from the last price of $0.3701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.568 | $6.648 | $6.5935 | +1,675% |
| February, 2028 | $5.626 | $6.447 | $6.3025 | +1,420% |
| March, 2028 | $5.1085 | $5.1485 | $5.0895 | +1,280% |
| April, 2028 | $4.9465 | $5.0665 | $4.983 | +1,237% |
| May, 2028 | $5.5576 | $5.201 | $5.5492 | +1,402% |
| June, 2028 | $5.067 | $5.137 | $5.3546 | +1,269% |
| July, 2028 | $4.925 | $4.9505 | $4.976 | +1,231% |
| August, 2028 | $4.6823 | $4.721 | $4.8095 | +1,165% |
| September, 2028 | $4.4808 | $4.5045 | $4.552 | +1,111% |
| October, 2028 | $3.3435 | $3.6635 | $3.97 | +803.40% |
| November, 2028 | $2.516 | $2.716 | $3.228 | +579.81% |
| December, 2028 | $2.514 | $2.625 | $2.494 | +579.27% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2029
The 2029 price forecast for X 4 Pharmaceuticals Inc Stock (XFOR) is $9.5867 on average, with a high prediction of $19.13 and a low estimate of $0.0435. This represents an +2,490% increase from the previous price of $0.3701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.3365 | $2.3965 | $2.3785 | +531.31% |
| February, 2029 | $2.5645 | $2.381 | $2.545 | +592.91% |
| March, 2029 | $2.4925 | $2.458 | $2.459 | +573.46% |
| April, 2029 | $2.4491 | $2.4615 | $2.407 | +561.73% |
| May, 2029 | $2.2627 | $2.311 | $2.3426 | +511.37% |
| June, 2029 | $2.011 | $2.05 | $2.1075 | +443.36% |
| July, 2029 | $1.6505 | $1.7656 | $1.8712 | +345.95% |
| August, 2029 | $1.3801 | $1.4232 | $1.508 | +272.89% |
| September, 2029 | $0.962 | $1.0595 | $1.2261 | +159.92% |
| October, 2029 | $0.112 | $0.677 | $0.804 | -69.75% |
| November, 2029 | $0.05 | $0.111 | $0.159 | -86.50% |
| December, 2029 | $19.20 | $0.0435 | $19.13 | +5,088% |
X 4 Pharmaceuticals Inc Stock (XFOR) Price Forecast for 2030
X 4 Pharmaceuticals Inc Stock (XFOR) is expected to reach an average price of $25.24 in 2030, with a high forecast of $26.71 and a low forecast of $23.77. This signifies an +6,719% surge from the last price of $0.3701.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $25.35 | $23.84 | $24.79 | +6,751% |
| February, 2030 | $24.80 | $24.76 | $24.27 | +6,601% |
| March, 2030 | $27.80 | $25.81 | $26.71 | +7,411% |
| April, 2030 | $25.84 | $25.98 | $26.39 | +6,881% |
| May, 2030 | $25.13 | $24.62 | $24.65 | +6,690% |
| June, 2030 | $25.14 | $25.34 | $25.07 | +6,693% |
| July, 2030 | $23.05 | $23.77 | $24.47 | +6,128% |
| August, 2030 | $25.48 | $25.53 | $24.95 | +6,786% |
| September, 2030 | $24.60 | $24.95 | $24.60 | +6,547% |
| October, 2030 | $25.65 | $25.60 | $25.79 | +6,831% |
| November, 2030 | $26.61 | $24.76 | $24.49 | +7,090% |
| December, 2030 | $25.14 | $25.79 | $25.06 | +6,692% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):